Physician profile
Ashmit Gupta
NPI 1245220151
$1,185.89
in general payments reported to CMS, 2019-2025
13 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $40.68 · 2021: $202 · 2022: $170 · 2023: $186 · 2024: $208 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $300.76 | 2022-2025 | Nucala |
| Optinose US, INC. | $235.96 | 2019-2024 | |
| Genzyme Corporation | $234.15 | 2020-2025 | |
| Medtronic USA, INC. | $94.97 | 2019 | |
| Alk-Abello, INC | $77.29 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $73.00 | 2019-2025 | Dupixent |
| Stryker Corporation | $41.51 | 2021-2022 | |
| Grifols USA, LLC | $32.86 | 2024-2025 | Xembify |
| Merck Sharp & Dohme LLC | $28.59 | 2021-2023 | |
| Medtronic, INC. | $24.31 | 2023 | Ligasure |
| Takeda Pharmaceuticals U.S.A., INC. | $15.82 | 2023 | Takhzyro |
| Eyevance Pharmaceuticals LLC | $14.43 | 2021 | |
| Boston Scientific Corporation | $12.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashmit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.